The WHO Regional Director for Europe, Dr Hans Henri P. Kluge, shared that the European Region accounts for 31% of COVID-19 cases and 43% of COVID-19 deaths globally. Dr Kluge highlighted that several countries continue to face increasing disease incidence and that “Preparing for the autumn is a priority now at the WHO Regional Office for Europe”.

WHO Director-General Dr Tedros, in his regular media briefing yesterday, highlighted that today is World Refugee Day and highlighted the risks of COVID-19 for some of the world’s most vulnerable people. He also stressed the shared duty to do everything we can to prevent, detect and respond to transmission of COVID-19 among refugee populations.

The hydroxychloroquine arm of the Solidarity Trial, which seeks to find an effective COVID19 treatment, is being stopped. The decision is based on evidence from the Solidarity Trial, the UK's Recovery trial and a Cochrane review of other evidence on hydroxychloroquine. Data shows that hydroxychloroquine does not result in the reduction of mortality of hospitalised COVID-19 patients, when compared with standard of care. 

The investigation of a cluster of COVID-19 cases in Beijing associated with a wholesale market continues. As of 18 June, 10AM CEST, Chinese authorities have reported a total of 172 cases since 11 June, including 158 in Beijing, 10 linked cases in Hebei Province, 2 in Liaoning Province, 1 in Sichuan Province and 1 in Zhejiang Province. Three genetic sequences related to Xinfadi cluster have been uploaded to the GISAID database. WHO is closely monitoring the situation and is in close contact with national authorities in China.